Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy - PubMed (original) (raw)
Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy
E Y Skolnik et al. J Exp Med. 1991.
Abstract
Advanced glycosylation endproducts (AGEs) are derived from the nonenzymatic addition of glucose to proteins. AGEs have been found to accumulate on tissue proteins in patients with diabetes, and their accumulation is thought to play a role in the development of diabetic complications. The finding that macrophages and endothelial cells contain AGE-specific receptors led us to examine whether mesangial cells (MCs) also possess a mechanism for recognizing and processing AGEs. Membrane extracts isolated from rat and human MCs were found to bind AGE-bovine serum albumin (BSA) in a saturable fashion, with a binding affinity of 2.0 +/- 0.4 x 10(6) M-1 (500 nM). The binding was specific for the AGE adduct, since AGE-modified collagen I and ribonuclease both competitively inhibited 125I-AGE-BSA binding to MC membranes, while the unmodified proteins did not compete. Binding of AGE proteins was followed by slow internalization and degradation of the ligand. Ligand blotting of MC membrane extracts demonstrated three distinct AGE-binding membrane proteins of 50, 40, and 30 kD. Growth of MCs on various AGE-modified matrix proteins resulted in alterations in MC function, as demonstrated by enhanced production of fibronectin and decreased proliferation. These results point to the potential role that the interaction of AGE-modified proteins with MCs may play in vivo in promoting diabetic kidney disease.
Similar articles
- Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism.
Pugliese G, Pricci F, Romeo G, Pugliese F, Mené P, Giannini S, Cresci B, Galli G, Rotella CM, Vlassara H, Di Mario U. Pugliese G, et al. Diabetes. 1997 Nov;46(11):1881-7. doi: 10.2337/diab.46.11.1881. Diabetes. 1997. PMID: 9356040 - Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties.
Esposito C, Gerlach H, Brett J, Stern D, Vlassara H. Esposito C, et al. J Exp Med. 1989 Oct 1;170(4):1387-407. doi: 10.1084/jem.170.4.1387. J Exp Med. 1989. PMID: 2551990 Free PMC article. - Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycosylation end products is mediated via platelet-derived growth factor.
Doi T, Vlassara H, Kirstein M, Yamada Y, Striker GE, Striker LJ. Doi T, et al. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2873-7. doi: 10.1073/pnas.89.7.2873. Proc Natl Acad Sci U S A. 1992. PMID: 1313571 Free PMC article. - Role of Amadori-modified nonenzymatically glycated serum proteins in the pathogenesis of diabetic nephropathy.
Cohen MP, Ziyadeh FN. Cohen MP, et al. J Am Soc Nephrol. 1996 Feb;7(2):183-90. doi: 10.1681/ASN.V72183. J Am Soc Nephrol. 1996. PMID: 8785386 Review. - Amadori-glycated albumin in diabetic nephropathy: pathophysiologic connections.
Chen S, Cohen MP, Ziyadeh FN. Chen S, et al. Kidney Int Suppl. 2000 Sep;77:S40-4. doi: 10.1046/j.1523-1755.2000.07707.x. Kidney Int Suppl. 2000. PMID: 10997689 Review.
Cited by
- Immune Modulation by Myeloid-Derived Suppressor Cells in Diabetic Kidney Disease.
Hsieh CC, Chang CC, Hsu YC, Lin CL. Hsieh CC, et al. Int J Mol Sci. 2022 Oct 31;23(21):13263. doi: 10.3390/ijms232113263. Int J Mol Sci. 2022. PMID: 36362050 Free PMC article. Review. - Glucagon-like peptide receptor agonists attenuate advanced glycation end products-induced inflammation in rat mesangial cells.
Chang JT, Liang YJ, Hsu CY, Chen CY, Chen PJ, Yang YF, Chen YL, Pei D, Chang JB, Leu JG. Chang JT, et al. BMC Pharmacol Toxicol. 2017 Oct 24;18(1):67. doi: 10.1186/s40360-017-0172-3. BMC Pharmacol Toxicol. 2017. PMID: 29065926 Free PMC article. - Constructing the toolbox: Patient-specific genetic factors of altered fracture healing.
Drissi H, Paglia DN, Alaee F, Yoshida R. Drissi H, et al. Genes Dis. 2014 Dec 1;1(2):140-148. doi: 10.1016/j.gendis.2014.07.006. Genes Dis. 2014. PMID: 25558470 Free PMC article. - Comprehensive identification of glycated peptides and their glycation motifs in plasma and erythrocytes of control and diabetic subjects.
Zhang Q, Monroe ME, Schepmoes AA, Clauss TR, Gritsenko MA, Meng D, Petyuk VA, Smith RD, Metz TO. Zhang Q, et al. J Proteome Res. 2011 Jul 1;10(7):3076-88. doi: 10.1021/pr200040j. Epub 2011 Jun 10. J Proteome Res. 2011. PMID: 21612289 Free PMC article. - AGE restriction in diabetes mellitus: a paradigm shift.
Vlassara H, Striker GE. Vlassara H, et al. Nat Rev Endocrinol. 2011 May 24;7(9):526-39. doi: 10.1038/nrendo.2011.74. Nat Rev Endocrinol. 2011. PMID: 21610689 Free PMC article. Review.
References
- Proc Natl Acad Sci U S A. 1984 Jan;81(2):583-7 - PubMed
- Diabetologia. 1984 May;26(5):361-5 - PubMed
- Clin Chim Acta. 1980 Jun 10;104(2):161-7 - PubMed
- Proc Natl Acad Sci U S A. 1979 Nov;76(11):5577-81 - PubMed
- J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical